Hiral Labs Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 6.98 Cr
as on 23-10-2024
- Company Age 24 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 7.20 Cr
as on 23-10-2024
- Revenue 16.48%
(FY 2023)
- Profit 16.64%
(FY 2023)
- Ebitda 13.83%
(FY 2023)
- Net Worth 27.63%
(FY 2023)
- Total Assets 18.23%
(FY 2023)
About Hiral Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.98 Cr.
The company currently has active open charges totaling ₹19.00 Cr. The company has closed loans amounting to ₹7.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Haiderali Saiyed, Amit Jajoo, and Fahed Saiyed serve as directors at the Company.
- CIN/LLPIN
U24231GJ2000PLC038759
- Company No.
038759
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hiral Labs Limited offer?
Hiral Labs Limited offers a wide range of products and services, including Juices, Soups & Soft Drinks, Instant Drink Mix, Antibiotic Tablets & Capsules, Azithromycin Tablets, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antibacterial Drugs.
Who are the key members and board of directors at Hiral Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Haiderali Saiyed  | Director | 09-Oct-2000 | Current |
| Amit Jajoo | Director | 25-May-2017 | Current |
| Fahed Saiyed | Director | 17-Jan-2022 | Current |
Financial Performance of Hiral Labs.
Hiral Labs Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.48% increase. The company also saw a substantial improvement in profitability, with a 16.64% increase in profit. The company's net worth Soared by an impressive increase of 27.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hiral Labs?
In 2023, Hiral Labs had a promoter holding of 42.56% and a public holding of 57.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raali Lifescience Private LimitedActive 7 years 11 monthsHaiderali Saiyed and Fahed Saiyed are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 05 May 2018 | ₹19.00 Cr | Open |
Others Creation Date: 25 Jul 2017 | ₹1.00 Cr | Satisfied |
Axis Bank Creation Date: 27 Aug 2012 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Hiral Labs?
Hiral Labs has a workforce of 218 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hiral Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hiral Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
